D Amp M Pharma Peru Sac [best]

In the heart of Lima’s San Isidro district, within a modern office on Av. Pablo Carriquiry 660

, a small team of 32 professionals works under the banner of D & M Pharma Peru S.A.C.

. This is not just a wholesale business; it is a vital link in a story of cross-border health innovation that began decades ago.

The roots of the company trace back to May 2003, when a group of Chilean executives with deep pharmaceutical experience launched D&M Pharma. Their vision grew rapidly, catching the eye of Argentina’s prestigious Laboratorio Cassará

, a giant with over 65 years of history. By 2006, this partnership crossed the Andes to establish roots in Peru, officially incorporating the Peruvian branch on August 1, 2007.

Today, the story of D & M Pharma Peru is told through the patients who use their specialized treatments: Dermatology : Solutions like for skin care and Verruplant for stubborn warts provide relief to thousands. Respiratory Care : Products such as

help Lima’s residents breathe easier in the city's unique humid climate. Innovation : From probiotic supplements like

to advanced ophthalmology lines, the company continues to expand its reach.

Led by experts like Vice President Mery Luz Peña García, the team remains dedicated to the conviction that pharmaceutical strength lies in a commitment to human life. For D & M Pharma, every shipment of medicine is a promise of better health delivered to the pharmacies and hospitals of Peru. they offer or how to contact their Lima office for business inquiries? Expand map D&M PHARMA | Desarrollos y Marqueting Farmacéutico

D & M Pharma Peru S.A.C. is a pharmaceutical wholesaler and importer based in Lima, Peru. Founded in 2007, the company specializes in distributing high-quality medications, particularly in the respiratory, dermatological, and ophthalmological Core Business & Partnerships International Ties : It serves as the Peruvian partner for Laboratorio Cassará

(Argentina), distributing their line of products since 2006. Specializations

: The company operates through several specialized divisions: d amp m pharma peru sac

: Focuses on dermatology, respiratory tracts, and biotechnology. Fouchard, Bailleul, & Feelderm : Specialized in dermatology. : Focused on ophthalmology. dympharmaperu.com Key Pharmaceutical Products

Based on regulatory filings and import records, their portfolio includes: D & M Pharma Peru S.A.C. Company Profile - EMIS

For D&M Pharma Perú S.A.C., a pharmaceutical wholesaler and representative founded in 2006 that specializes in respiratory and dermatological products, a high-impact feature would be a "Pharma-Direct Traceability Portal." Feature: Pharma-Direct Traceability Portal

Since D&M Pharma focuses on being a strategic bridge between international manufacturers (like Laboratorio Cassará) and the Peruvian market, this feature would enhance their core commitment to quality and transparency.

Lot-Specific Verification: A digital tool allowing healthcare providers and pharmacies to scan a code on the product packaging (such as their respiratory or aerosoltherapy lines) to instantly verify the batch's origin and compliance with DIGEMID (Peru's regulatory authority) standards.

Real-time Pharmacovigilance Integration: An easy-access button for doctors to report adverse reactions directly to D&M Pharma's dedicated pharmacovigilance team, which is already a highlighted contact point on their Official Website.

Dynamic Inventory for Clinicians: A "Check Local Availability" map for doctors to see which nearby pharmacies currently have stock of specialized lines like Cassará, ensuring patients can fill their prescriptions without delay. Why this fits:

D&M Pharma operates in a niche involving 32 employees in San Isidro, Lima, emphasizing "Marketing and Development" (Desarrollos y Marqueting). Adding a digital layer that connects their marketing efforts with real-time safety and logistics data would position them as a more modern, tech-forward partner in the growing Peruvian pharmaceutical market.

DIGEMID - General Directorate of Medicines, Supplies and Drugs

D&M Pharma Perú S.A.C. is a specialized pharmaceutical company based in Lima, Peru, that focuses on the distribution and marketing of high-quality therapeutic solutions. Established in 2006, the company acts as a strategic gateway for international pharmaceutical lines—most notably the Argentine Laboratorio Cassará —to reach the Peruvian healthcare market. Corporate Identity and Strategic Origins

D&M Pharma (short for "Desarrollos y Marketing Farmacéutico") was originally founded in Chile in 2003 by executives with extensive industry expertise. International Partnership: In the heart of Lima’s San Isidro district,

In 2005, the company formed a partnership with Laboratorio Cassará, a prestigious Argentine laboratory with over 75 years of experience. Peruvian Launch: The company officially began operations in Peru in August 2007

(though its presence dates to 2006) to consolidate its international reach through the Cassará line. Current Scale:

As of late 2024, the enterprise operates with a team of approximately 32 employees out of its headquarters in San Isidro, Lima Therapeutic Specializations

The company’s portfolio is defined by its collaboration with various specialized divisions, providing medical professionals and patients with targeted treatments: Respiratory & Aerosol Therapy:

Recognized across Latin America for advanced treatments in asthma and other pulmonary conditions. Dermatology: Through divisions like Fouchard, Bailleul, and Feelderm

, they offer specialized skin care and clinical dermatological products. Ophthalmology: Managed under the Biotecnología:

Integration of biotechnology into their medicinal development, particularly through the Cassará division. Regulatory Compliance & Quality Standards

D&M Pharma Perú operates under strict adherence to national and international pharmaceutical standards. Standards: They follow the Good Storage Practices (BPA)

and technical norms established by the Peruvian Ministry of Health. Pharmacovigilance:

The company maintains robust drug safety protocols to monitor and report adverse events to the (the Peruvian regulatory authority). Recent Leadership & Recognition

The company continues to hold a significant voice in the Peruvian health sector. Notably, in April 2026 , the company's Technical Director, Dra. Mery Luz Peña García medical device importer

, was elected as Vice President of the Medicines Sector Board for the COMSALUD Gremio de Salud of the Lima Chamber of Commerce. or information on how to contact their regulatory department D & M Pharma Peru S.A.C. Company Profile - EMIS 31-Oct-2024 —

Future Outlook and Expansion Potential

The Peruvian pharmaceutical market is projected to grow at a CAGR of 5–7% through 2030, driven by an aging population, rising chronic disease prevalence, and expanded healthcare coverage under Universal Health Insurance (SIS). For D amp M Pharma Peru SAC, several growth avenues exist:

  • E-pharma integration – Partnering with digital platforms like Farmalisto or FarmaPeru for last-mile delivery of wholesale orders.
  • Regional export – Leveraging Peru’s trade agreements to distribute into Bolivia, Ecuador, or Chile.
  • Specialization in biosimilars – As high-cost biologics lose patent protection, demand for temperature-controlled biosimilar distribution will surge.

If the company successfully secures more DIGEMID authorizations for advanced therapies (e.g., gene therapy vectors or monoclonal antibodies), it could ascend from a mid-tier wholesaler to a specialty logistics leader.

Customs Classification (Subpartida Nacional)

Their products likely fall under HS Code heading 30 (Pharmaceutical products). Specifically:

  • 3004.90.20.00 – Medicaments for human use.
  • 3003.90.00.00 – APIs.

If D & M Pharma Peru SAC has a strong import record, they must be registered in the Drawback regime, allowing them to recover taxes on re-exports.

Supply Chain and Logistics in Peru

One of the most challenging aspects of operating in Peru is the geography. From the arid coast to the high-altitude Andes and the humid Amazon, maintaining the cold chain for vaccines and biologics is a monumental task. D amp M Pharma Peru SAC has invested in:

  • Temperature-controlled warehousing in Lima’s industrial zones (e.g., Callao and Ate).
  • Real-time IoT monitoring for shipments to remote regions like Iquitos or Puno.
  • Emergency contingency plans for road closures (common due to landslides or protests).

The company’s distribution network relies on a mix of third-party logistics (3PL) carriers and its own fleet of temperature-monitored vans for high-value or time-sensitive orders.

Market Position and Competitive Landscape

The Peruvian pharmaceutical distribution market is moderately concentrated, with major players like Farmacias Peruanas, MiFarma, and Corbeta dominating retail. However, D amp M Pharma Peru SAC occupies a valuable niche: institutional and sub-distribution.

Unlike retail giants, D amp M Pharma Peru SAC does not typically own storefront pharmacies. Instead, it acts as a secondary wholesaler or specialized logistics provider for:

  • Small to mid-sized regional pharmacy chains.
  • Private clinics in Lima, Arequipa, Trujillo, and Cusco.
  • NGO health programs in the Amazon and Andean highlands.

This model reduces overhead while allowing the company to serve hard-to-reach areas where major distributors have thin coverage.

5. Financial Health (if available)

  • No public financial statements are required for S.A.C. entities in Peru unless they exceed certain thresholds or voluntarily publish.
  • You may request from the company:
    • Last 2–3 years of balance sheet & P&L
    • Certificación de ingresos y retenciones (ITF, IGV, Renta)
  • Alternative: Contract a credit risk report from Equifax (Infocorp Empresas) or Sentinel Peru.

4. Due Diligence Checklist (Before Business Engagement)

If you are considering:

  • Purchasing products from D & M Pharma Peru S.A.C.
  • Selling products to them.
  • Partnering for distribution or import.

✅ Request these documents:

  1. Certificado de Vigencia de Poder (Proof of current legal representation) – from Registros Públicos.
  2. DIGEMID Authorization (including the specific category: drug distributor, medical device importer, etc.).
  3. Last 2 years’ financial statements (if they are required to file – S.A.C. companies may have limited disclosure unless they exceed certain revenue thresholds).
  4. Bank references and a proof of tax compliance (Certificado de No Adeudo from SUNAT).